215 related articles for article (PubMed ID: 9233515)
1. Changes in plasma luteinizing hormone, testosterone and estradiol-17 beta levels and semen quality after injections of gonadotropin releasing hormone agonist and human chorionic gonadotropin in three dogs with oligozoospermia and two dogs with azoospermia.
Kawakami E; Hori T; Tsutsui T
Anim Reprod Sci; 1997 May; 47(1-2):157-67. PubMed ID: 9233515
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma LH and testosterone levels and semen quality after a single injection of hCG in two dogs with spermatogenic dysfunction.
Kawakami E; Hori T; Tsutsui T
J Vet Med Sci; 1998 Jun; 60(6):765-7. PubMed ID: 9673954
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma testosterone levels and semen quality after 3 injections of a GnRH analogue in 3 dogs with spermatogenic dysfunction.
Kawakami E; Masaoka Y; Hirano T; Hori T; Tsutsui T
J Vet Med Sci; 2005 Dec; 67(12):1249-52. PubMed ID: 16397384
[TBL] [Abstract][Full Text] [Related]
4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
5. Changes in peripheral plasma luteinizing hormone and testosterone concentrations and semen quality in normal and cryptorchid dogs during sexual maturation.
Kawakami E; Tsutsui T; Saito S; Kakimoto T; Ogasa A
Lab Anim Sci; 1995 Jun; 45(3):258-63. PubMed ID: 7650895
[TBL] [Abstract][Full Text] [Related]
6. Improvement in spermatogenic function after subcutaneous implantation of a capsule containing an aromatase inhibitor in four oligozoospermic dogs and one azoospermic dog with high plasma estradiol-17beta concentrations.
Kawakami E; Hirano T; Hori T; Tsutsui T
Theriogenology; 2004 Jul; 62(1-2):165-78. PubMed ID: 15159111
[TBL] [Abstract][Full Text] [Related]
7. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of aromatase inhibitor in two azoospermic dogs with high plasma estradiol-17beta levels.
Kawakami E; Taguchi N; Hirano T; Hori T; Tsutsui T
J Vet Med Sci; 2003 Dec; 65(12):1343-5. PubMed ID: 14709824
[TBL] [Abstract][Full Text] [Related]
9. Effects of LHRH-analogue treatment of spermatogenic dysfunction in the dog.
Kawakami E; Tonsho H; Tsutsui T; Ogasa A
Int J Androl; 1991 Dec; 14(6):441-52. PubMed ID: 1761324
[TBL] [Abstract][Full Text] [Related]
10. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
11. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men.
Matsumoto AM; Bremner WJ
J Androl; 1985; 6(3):137-43. PubMed ID: 3922931
[TBL] [Abstract][Full Text] [Related]
14. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
15. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
[TBL] [Abstract][Full Text] [Related]
16. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
17. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
18. Secondary treatment failure without anti-human chorionic gonadotropin antibody in a patient with Kallmann syndrome.
Kitahara S; Yoshida K; Ishizaka K; Higashi Y; Takagi K; Oshima H
Int J Urol; 1998 Jul; 5(4):398-400. PubMed ID: 9712456
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin and gonadal steroid release in response to a gonadotropin-releasing hormone agonist in Gqalpha and G11alpha knockout mice.
Stanislaus D; Janovick JA; Ji T; Wilkie TM; Offermanns S; Conn PM
Endocrinology; 1998 Jun; 139(6):2710-7. PubMed ID: 9607776
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma testosterone level and semen quality after frequent injections of GnRH analogue in a Beagle dog with azoospermia.
Kawakami E; Hori T; Tsutsui T
J Vet Med Sci; 2009 Oct; 71(10):1373-5. PubMed ID: 19887745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
